Zydus Cadila to market oxybutynin chloride tablets in USA
Zydus Cadila has received final USFDA approval to market oxybutynin chloride tablets in USA. The drug is used to treat overactive bladder and urinary incontinence […]
Zydus Cadila has received final USFDA approval to market oxybutynin chloride tablets in USA. The drug is used to treat overactive bladder and urinary incontinence […]
Natco Pharma Ltd has got the final USFDA approval for the generic version of Vidaza (Azacitidine for injection, 100 mg per vial), single-dose vial. Natco […]
Glenmark Pharmaceuticals has received final USFDA approval for its generic version of anti-inflammatory drug Indomethacin tablets. The drug is the generic equivalent of Indocin SR […]
Unichem Laboratories has received final USFDA approval for Piroxicam capsules, used in the treatment of osteoarthritis and rheumatoid arthritis, in the US market. The approved […]
Lupin has received final USFDA approval to market a generic version of Novartis’ inhalation product Tobi, which is used to treat cystic fibrosis, in the […]
Alembic Pharmaceuticals has received final USFDA approval for Fenofibric acid delayed-release capsules used for lowering high cholesterol and increasing good cholesterol. The approved product is […]
Alembic Pharmaceuticals has received final USFDA approval for two anti-hypertension tablets – olmesartan medoxomil tablets, 5 mg, 20 mg, and 40 mg and olmesartan medoxomil […]
Wockhardt has received USFDA approval to market generic version of Wyeth’s Zosyn, used for treating bacterial infections, in the American market. Wockhardt Bio AG had […]
Glenmark Pharmaceuticals has received USFDA approval for Clobetasol Propionate Ointment used for treatment of various skin conditions. The approved product is a generic version of […]
Lupin Ltd has received final USFDA approval to market sodium sulfate, potassium sulfate, magnesium sulfate oral solution used in colonoscopy. The company will market sodium […]
Copyright © 2026 | WordPress Theme by MH Themes